Book Navigation
x

We are sorry, but signing in with LinkedIn is not possible at this time.

 

Amir Qaseem, MD, PhD, MHA, FACP

GIN Chair from 2012/2013 and 2013/14; Member of the GIN Board of Trustees since 2010/2011 - 2019, 2020 - 2023; Member of the GIN Conference Scientific Committee 2010, 2012, 2016 and 2018.

 

Amir Qaseem, MD, PhD, MHA, MRCP (London), FACP

Biography

Dr. Qaseem is trained as a physician, health economist, methodologist, clinical epidemiologist, business administrator, and a leader. He is responsible for leading the American College of Physicians' evidence-based medicine and clinical practice guidelines program, oldest program in the United States. Dr. Qaseem also leads ACP's quality indicators, performance measures, and population health programs. He directs ACP’s high value care initiative and scientific medical policy evaluating and publishing the benefits, harms, and costs of various overused, misused, and underused diagnostic tests and therapeutic interventions. Dr. Qaseem’s work includes development and implementation of ACP’s quality improvement and educational programs. Dr. Qaseem’s is also involved in clinical care and research addressing priority populations, elderly, women, multiple chronic conditions, end of life care, genetics, and determinants of health. 

 

Dr. Qaseem has led and participated in decisions varying from organisational level strategies to national level clinical priorities and policies in the United States. Dr. Qaseem has also been involved in multiple international collaborations to develop health policy, assess and evaluate quality of care, and develop quality improvement strategies and programs in countries in Asia, Australia, Europe, North America, and South America. Dr. Qaseem has published extensively in peer reviewed journals, of which over a hundred papers have been published in the top 5 medical journals in the world on topics such as clinical guidelines, implementation of clinical guidelines, pandemic crisis, quality improvement, performance measures and measurement, population health, and health policy related issues. Some of the papers authored by Dr. Qaseem are in the top ten most read articles in the Annals of Internal Medicine. Dr. Qaseem has been invited to speak as a keynote speaker and has presented at several national and international conferences on issues related to health policy, evidence-based medicine, population and public health, guideline development, guideline and evidence grading, performance measurement, and quality of care. 

Dr.  Qaseem has been interviewed for his expertise by journalists from TV, Radio, and

Print/Internet for many high-profile media outlets such as BBC, CNN, NBC, Reuters, the Washington Post, the New York Times, and the Wall Street Journal to name a few. Dr. Qaseem brings over 20 years of experience that includes working on different types of boards and committees, including governance boards, of various national and international organisations. This includes World Health Organization (WHO), National Quality Forum (NQF), Centers for

Disease Control and Prevention (CDC), Measures Application Partnership, Cochrane, GRADE Working Group, Guidelines International Network (GIN), Physician Consortium for Performance Improvement (PCPI), and Health Level Seven International (HL7)/FHIR. 

  

Vision for GIN 

I believe GIN offers a tremendous opportunity for us to pool our resources and exchange knowledge to help develop guidance to provide high quality care to our patients based on best available evidence. Reducing duplication and better coordination of evidence synthesis is more important than ever considering the current COVID-19 pandemic affecting us all. Seeking out quick wins to support those involved in this arena and making policy decisions is urgently needed. I would like to engage and work with you together to see GIN become a trusted source for guideline developers, users, implementers, and policy makers during this pandemic and beyond. Delivering value to our members, focusing on increasing our membership, and ensuring sustainability including financial stability of GIN will be critical during these turbulent times. It is imperative to explore and time is now to implement alternate networking and communication strategies to continue our discussions, promote sharing of knowledge, and progress our work forward in the absence of our traditional annual conference. Identifying and establishing new partnerships with leading organisations with mission and goals aligned with  GIN is urgently needed to ensure that science continues to form the foundation of our work and policies at the national and global level. We need to work closely with the experts and organisations involved in quality measurement, technology assessments, and health information technology to lead efforts such as development of quality indicators and standards for computable representations of clinical guidelines. Fostering and building new leaders among GIN members is critical to steer our network into the next decade. We need to understand and act on addressing diversity and variation in the needs across individuals, populations, and regions. Considering the intellectual brainpower of the GIN members, I would like to prioritize listening to our members, brainstorm together to identify potential opportunities, ideas, future direction, and solutions for GIN, to ensure that our organisation continues to provide value in a rapidly changing environment.  

 

Page last updated: Oct 01, 2020
Back to top